Gara Jalqabaatti › Lymphoma Zoonii Gamaa
Qorannoo klinikaalii Lymphoma Zoonii Gamaa Ameerikaa Keessatti hirmaatuu
Qorannoo 56 Lymphoma Zoonii Gamaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Durham, NCQorannoo 12
- New York City, NYQorannoo 11
- Boston, MAQorannoo 9
- Seattle, WAQorannoo 9
- Milwaukee, WIQorannoo 9
- Baldwin Park, CAQorannoo 9
- Rochester, MNQorannoo 8
- Houston, TXQorannoo 8
- Columbus, OHQorannoo 8
- Edison, NJQorannoo 8
- Nashville, TNQorannoo 7
- Miami, FLQorannoo 7
- Denver, COQorannoo 7
- Jacksonville, FLQorannoo 6
- St. Louis, MOQorannoo 6
- Salt Lake City, UTQorannoo 6
- Washington, DCQorannoo 5
- Atlanta, GAQorannoo 5
- Queens, NYQorannoo 5
- Portland, ORQorannoo 5
- Cleveland, OHQorannoo 5
- Dallas, TXQorannoo 5
- Chicago, ILQorannoo 5
- Greenburgh, NYQorannoo 5
- Buffalo, NYQorannoo 4
- Tampa, FLQorannoo 4
- Cincinnati, OHQorannoo 4
- Los Angeles, CAQorannoo 4
- Philadelphia, PAQorannoo 4
- Staten Island, NYQorannoo 4
- New Rochelle, NYQorannoo 4
- Minneapolis, MNQorannoo 4
- Mountain View, CAQorannoo 3
- Cedar Rapids, IAQorannoo 3
- Richmond, VAQorannoo 3
- Scottsdale, AZQorannoo 3
- Ann Arbor, MIQorannoo 3
- Providence, RIQorannoo 3
- San Francisco, CAQorannoo 3
- New Haven, CTQorannoo 3
Naannoon
- ArizonaQorannoo 5
- CaliforniaQorannoo 18
- ColoradoQorannoo 8
- ConnecticutQorannoo 4
- FloridaQorannoo 15
- GeorgiaQorannoo 6
- IllinoisQorannoo 6
- IowaQorannoo 4
- KansasQorannoo 3
- MarylandQorannoo 6
- MassachusettsQorannoo 12
- MichiganQorannoo 5
- MinnesotaQorannoo 12
- MissouriQorannoo 6
- New JerseyQorannoo 9
- New YorkQorannoo 16
- North CarolinaQorannoo 14
- OhioQorannoo 13
- OregonQorannoo 5
- PennsylvaniaQorannoo 5
- Rhode IslandQorannoo 3
- TennesseeQorannoo 8
- TexasQorannoo 12
- UtahQorannoo 6
- VirginiaQorannoo 4
- WashingtonQorannoo 10
- WisconsinQorannoo 10
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07763210A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07231952Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07583810Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06350318Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT00923507Epco, Zanu, Ritux for R/R FL or MZL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06563596Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT04840602A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05296070Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07225439A Study of ARC-02 in B-cell NHL
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT04792502A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06149286AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06340737HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06792825LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 81 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05990465Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06708897A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07424833This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07121946Allo HSCT Using RIC and PTCy for Hematological Diseases
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 75 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT05805605A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05131022Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06860880Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06905509Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.